| Code | 6957A | ||||||||||
| MA number | EU/1/00/145/002 | ||||||||||
| Product Form: | sol inj 1x5 ml (liek.inj.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Roche Registration GmbH, Germany | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 21 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 28.08.2000 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC Herceptin falšovanie 5 5 2014.pdf
|
| Safety feature | Yes |
| Data update: | 27.08.2024 |
